Intellijoint Surgical™ is a privately held Canadian medical device company committed to assisting orthopaedic surgeons meet their surgical objectives. Focused first on hip surgery, Intellijoint Surgical’s affordable Smart Tools enhance surgeon accuracy, improve patient outcomes and increase hospital economic efficiencies. intellijoint HIP™ is a low cost, easy to use Smart Tool that assists surgeons with accurate selection, positioning and alignment of implants during hip replacement surgery. The device uses a combination of hardware and software, and integrates miniature optical sensors and microelectronics. Without altering surgical techniques or workflow, intellijoint HIP provides surgeons with quantitative intra-operative data regarding changes in cup position, leg length and offset while adding approximately 3-5 minutes to surgery. This data expedites decision-making and improves accuracy in achieving pre-operative planned targets, ultimately improving patient outcomes and reducing outliers. Our flagship product, intellijoint HIP, was initially born out of a final year university design project. Engineer Armen Bakirtzian came up with the idea for a product to make hip replacement surgeries more accurate after discussions with his orthopaedic surgeon father. Armen teamed up with colleagues Richard Fanson and Andre Hladio to pitch the idea at Next Top Young Entrepreneur Start-Up Pitch Competition in 2010. After winning the competition and securing an initial round of investment, the three entrepreneurs co-founded Intellijoint Surgical and began the journey to bring intellijoint HIP* to market. Today, intellijoint HIP* has obtained both a Health Canada license and has been cleared by the FDA. The product has been utilized by surgeons in over 200 procedures in the US and Canada. The company will continue to expand into other areas, include knee arthroplasty in the near future.

Intellijoint Surgical™ is a privately held Canadian medical device company committed to assisting orthopaedic surgeons meet their surgical objectives. Focused first on hip surgery, Intellijoint Surgical’s affordable Smart Tools enhance surgeon accuracy, improve patient outcomes and increase hospital economic efficiencies. intellijoint HIP™ is a low cost, easy to use Smart Tool that assists surgeons with accurate selection, positioning and alignment of implants during hip replacement surgery. The device uses a combination of hardware and software, and integrates miniature optical sensors and microelectronics. Without altering surgical techniques or workflow, intellijoint HIP provides surgeons with quantitative intra-operative data regarding changes in cup position, leg length and offset while adding approximately 3-5 minutes to surgery. This data expedites decision-making and improves accuracy in achieving pre-operative planned targets, ultimately improving patient outcomes and reducing outliers. Our flagship product, intellijoint HIP, was initially born out of a final year university design project. Engineer Armen Bakirtzian came up with the idea for a product to make hip replacement surgeries more accurate after discussions with his orthopaedic surgeon father. Armen teamed up with colleagues Richard Fanson and Andre Hladio to pitch the idea at Next Top Young Entrepreneur Start-Up Pitch Competition in 2010. After winning the competition and securing an initial round of investment, the three entrepreneurs co-founded Intellijoint Surgical and began the journey to bring intellijoint HIP* to market. Today, intellijoint HIP* has obtained both a Health Canada license and has been cleared by the FDA. The product has been utilized by surgeons in over 200 procedures in the US and Canada. The company will continue to expand into other areas, include knee arthroplasty in the near future.

Leveraging linkage capability of the platform, its easy-to-use format allows clinical team members to access, share and understand service line profitability so that organizations have a comprehensive approach and understanding of how to become financially sustainable.

• Identifying top and bottom performing service lines within the organization to drive short- and long-term strategies
• Identifying physician ordering patterns by encounter/case type to allow for potential purchasing consolidation by supply type or item
• Drawing attention to potential revenue shortages that are contributing to negative service line margin performance
• Establishing physician-level utilization and related costs to help determine high-cost Diagnosis Related Groups (DRGs)/procedures in tandem with patient/encounter severity to allow internal benchmarking and improvement initiatives

Founded in 1993, MedeAnalytics is an innovation-focused company. Over the past three decades, we have worked tirelessly to reimagine healthcare through the power of data—and helped thousands of organizations achieve their potential along the way.

Leveraging state-of-the-art analytics and data activation, MedeAnalytics delivers actionable insights that support payers, providers, employers, and public entities as they navigate the complex healthcare landscape.

Using artificial intelligence and machine learning alongside the most advanced data orchestration in the industry, we empower organizations to optimize their resource allocation, experience superior patient outcomes, and achieve population health management goals.